AxelrodJ., WeinsrilboumR.: Catecholamines. New Eng. J. Med., 287; 237–242 (1972).
2.
BaxterJ. D., ForshamP. H.: Tissue effects of glucocorticoids. Amer. J. Med., 53; 573 (1972).
3.
BeckwithJ. B., PerrinE. V.: In situ neuroblastoma; its contribution to the natural history of neural crest tumors. Amer. J. Pathol., 43; 1089–1104 (1963).
4.
BoeyJ. H., CookeI. J. C., GilbertJ. M., SweeneyE. C., TaylorS.: Occurrence of other endocrine tumors in primary hyperparathyroidism. Lancet, 2; 781–784 (1975).
5.
BongiovanniA. M., EbesleinW. R.: Disorders of adrenal steroid biogenesis. Rec. Progr. Res., 23; 375 (1967).
6.
BreslowN., McCannB.: Statistical estimation of prognosis for children with neuroblastoma. Cancer Res., 31; 2098–2103 (1971).
7.
BrownR. D., Van LoonG. R.: Cushing's syndrome with periodic hormonogenesis: one explanation for paradoxical response to desamethasone. J. Clin. Endocrinol., 36; 445 (1973).
8.
BrunB., JoshiM. S., GrønvallS., HolmH. H.: Dynamic ultrasound evaluation of tumor thrombus in the inferior vena cava. Scand. J. Urol. Nephrol., 17; 115 (1983).
9.
ConnJ. W.: Plasma renin activity in primary aldosteronism. Importance in differential diagnosis and in research of essential hypertension. J.A.M.A., 190; 222 (1964).
10.
DidolkarM. S., BescherR. A., EliasE. G., MooreR. H.: Natural history of adrenal cortical carcinoma: a clinicopathologic study of 42 patients. Cancer, 47; 2153 (1981).
LipsettM. B., HertzR., RossG. T.: Clinical and pathophysiologic aspects of adrenocortical carcinoma. Amer. J. Med., 35; 374 (1963).
17.
LuetscherJ. A., DowdyA. J.: Studies of secretion and metabolism of aldosterone and cortisol. Trans. Assoc. Amer. Physicians, 75; 293 (1962).
18.
LuetscherJ. A.: Studies of aldosterone in relation to water and electrolyte balance in man. Rec. Prog. Horm. Res., 12; 175 (1956).
19.
MartoranaG., GibertiC., PescatoreD., GiulianiL.: Preoperative evaluation of adrenal cortical carcinoma extending into the inferior vena cava. J. Urol., 128; 792 (1982).
20.
NicholsonW. E., LiddleR. A.: Adrenocorticotropic hormone biotransformation, clearance, and catabolism. Endocrinology, 103; 1344 (1978).
21.
OrthD. N., LiddleG. W.: Results of treatment in 108 patients with Cushing's syndrome. N. Engl. J. Med., 285; 243 (1971).
22.
RichieJ. P., GittesH. F.: Carcinoma of the adrenal cortex. Cancer, 45; 1957 (1980).
23.
SamuelsL. T., UchikawaT.: Biosynthesis of adrenal steroids. In: The Adrenal Cortex, p. 61, EisensteinA. B. (ed.), Little Brown & Co., Boston1967.
24.
SandbergA. A., SlaunwriteW. R.Jr.: Physical state of adrenal cortical hormones in plasma. In: The Human Adrenal Cortex, p. 69, ChristyN. P. (ed.), Harper & Row, New York1971.
25.
SissonJ. C., FragerM. S., ValkT. W., GrossM. D., SwansonD. P., WeilandD. M., TobersM. C., BeierwaltesW. H., ThompsonN. W.: Scintigraphic localization of pheochromocytoma. N. Engl. J. Med., 305; 12 (1981).
26.
TempleT. E., LiddleG. W.: Inhibitors of adrenal steroid biosynthesis. Ann. Rev. Pharmacol., 10; 199 (1970).